AVEO Oncology to Present at the Canaccord Genuity 33rd Annual Growth
Canaccord Genuity Global Growth Conference 2013
CAMBRIDGE, Mass. -- August 9, 2013
AVEO Oncology (NASDAQ: AVEO) today announced that David Johnston, chief
financial officer, is scheduled to present at the Canaccord Genuity 33^rd
Annual Growth Conference on Thursday, August 15, 2013 at 2:00 p.m. (ET) in
A live webcast of AVEO’s presentation can be accessed by visiting the
investors section of the company’s website at investor.aveooncology.com. A
replay of the webcast will be archived on the AVEO website for two weeks
following the presentation.
AVEO Oncology (NASDAQ: AVEO) is a cancer therapeutics company committed to
discovering, developing and commercializing targeted therapies to impact
patients’ lives. AVEO’s proprietary Human Response Platform^TM provides the
company unique insights into cancer biology and is being leveraged in the
discovery and clinical development of its cancer therapeutics. For more
information, please visit the company’s website at www.aveooncology.com.
David Johnston, 617-299-5810
Kristie Wallis, 336-774-8666
Press spacebar to pause and continue. Press esc to stop.